CERS Earnings

CERS reported its FY2025Q4 earnings on 2026-03-02, showcasing a revenue of 57.75M against an estimate of , resulting in a 0% surprise. The EPS was -0.01, surpassing the expected -0.01 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CERS's FY2025Q4 earnings announcement on 2026-03-02, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CERS's stock price tends to shift by an average of 1.63% in the 10 days leading up to earnings and 2.4% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate CERS's annual revenue to reach 51.63M, while the EPS is projected at -0.03. These estimates reflect recent revisions, with revenue estimates revised upward by 4.55% and EPS estimates revised upward by 4.71% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CERS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 4.55%, while EPS estimates moved revised upward by 4.71%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CERS's stock price typically moves by 1.63% in the 10 days before its earnings and 2.4% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of -0.03 and revenue of 51.63M.

The earnings call summary shows strong financial performance with a 16% revenue increase and positive EBITDA. The company raised guidance and anticipates record Q4 2025 revenue. Despite margin pressures, growth in EMEA and North America, and strong product demand, particularly in the IFC segment, are positive signals. The Q&A reveals optimism about market penetration and future cash flows. While there are concerns about production costs and the BARDA contract expiration, the overall sentiment is positive, suggesting a 2% to 8% stock price increase over the next two weeks.